Provider Resource

Digital vs. Drug Addictions: Shared Circuits, Real Differences

Digital and drug addictions overlap substantially in their behavioral phenomenology and reward-system neurobiology, which is why the same diagnostic language is increasingly applied to both. But they diverge in the presence of an exogenous toxic substance, the severity of withdrawal, the natural course, and the strength of the evidence supporting "addiction" status at all. The clearest framing is that behavioral (digital) addictions and substance use disorders (SUDs) appear to be different clinical expressions of a shared underlying addiction syndrome, rather than identical entities.

Scope and framing

"Digital addiction" is an umbrella term covering internet gaming disorder (IGD), broader internet addiction, problematic smartphone use, and social media addiction. Only gambling disorder is fully recognized as a behavioral addiction in both DSM-5-TR and ICD-11, and gaming is the digital behavior with by far the most neurobiological and clinical data. This review therefore draws most heavily on gaming, extrapolating to phone, internet, and social media use where evidence permits.

How they are the same

Shared reward circuitry and dopamine signaling: The mesolimbic dopamine pathway (ventral tegmental area to nucleus accumbens) is the common substrate. PET studies show video-game play produces striatal dopamine release comparable in magnitude to drugs of abuse. As in chronic substance use, IGD is associated with reduced striatal D2 receptor availability, correlating with addiction severity and years of overuse, and with decreased dopamine transporter density, indicating presynaptic dopaminergic dysfunction analogous to SUDs. A direct comparison of IGD and tobacco use disorder found the same wanting-liking dissociation predicted by the incentive-sensitization model: pathological "wanting" (craving) exceeding hedonic "liking."
Shared prefrontal and fronto-striatal dysfunction: Both categories show reduced gray matter and cortical thickness in the orbitofrontal cortex, dorsolateral prefrontal cortex, and anterior cingulate, with impaired top-down inhibitory control. Both display an imbalance between a weakened executive-control network and an over-active reward network, and a ventral-to-dorsal striatal shift consistent with the transition from goal-directed use to compulsive habit.
Convergent transdiagnostic neuroimaging: A transdiagnostic voxel-based morphometry meta-analysis (108 studies; roughly 4,900 patients with SUD or behavioral addiction versus 4,800 controls) found that combining substance and behavioral addictions revealed 24 additional shared regions, including bilateral insula, lentiform nucleus, amygdala, hippocampus, and frontal/temporal cortex, supporting a unified "Syndrome Model of Addiction." An activation-likelihood meta-analysis of 144 fMRI studies similarly found that IGD shared frontal and cingulate alterations with all SUDs.
Shared clinical phenomenology: Both share the core components of addiction: salience and preoccupation, craving, mood modification, loss of control, continued use despite harm, and relapse. Comorbidity profiles overlap heavily (depression, anxiety, ADHD, impulsivity), individuals with IGD frequently co-use substances, and there is partial genetic overlap in dopaminergic (D2 receptor, COMT) and stress-axis (CRHR1) genes. Both also respond to the same first-line psychotherapy, CBT.

How they are different

No exogenous substance, no direct toxicity: The fundamental distinction: digital addictions perturb reward neurochemistry only through endogenous mechanisms, with no ingested drug acting on receptors. Consequently there is no organ toxicity, no overdose risk, and no pharmacological lethality. Structural brain changes in gaming reflect experience-dependent neuroplasticity rather than neurotoxicity: IGD shows enlarged hippocampal volume, whereas alcohol use disorder shows neurotoxic volume loss.
Divergent neural signatures: Despite shared circuitry, meta-analysis finds that SUDs show reduced nucleus accumbens response to non-drug rewards and reduced parietal activation during cognitive control, whereas behavioral addictions show enhanced reward responses (putamen/globus pallidus) and no significant cognitive-control deficits versus controls, suggesting a preserved motivation-control equilibrium rather than the dual-system breakdown of SUDs.
Milder and contested withdrawal and tolerance: Withdrawal in digital addictions is predominantly affective (irritability, anxiety, low mood) and lacks the physiologically dangerous syndromes (seizures, delirium tremens, autonomic instability) of alcohol or opioid withdrawal. Tolerance is genuinely debated: spending progressively more time may reflect skill acquisition or enthusiasm rather than pathological neuroadaptation. Notably, ICD-11 deliberately excluded tolerance and withdrawal from its gaming disorder criteria as "not relevant."
More benign natural history: Digital addictions, especially in adolescents, are often transient and episodic with high rates of spontaneous remission: 14 to 59% recover within 1 to 2 years without formal treatment, and a 5-year longitudinal study found symptom severity across six behavioral addictions declined substantially without intervention. SUDs also carry an enormous directly attributable mortality burden (standardized mortality ratios roughly 3 to 15 times), which has essentially no counterpart in digital addiction apart from gambling-related suicide.

Diagnostic status: the same criteria, unequal recognition

The DSM-5 modeled its IGD criteria directly on substance use and gambling disorders, requiring at least 5 of 9 criteria over 12 months (preoccupation, withdrawal, tolerance, loss of control, loss of other interests, continued use despite problems, deception, escape or mood regulation, functional consequences) plus clinically significant impairment. IGD remains in DSM-5-TR Section III as a "condition for further study," not a formal diagnosis. ICD-11 went further, recognizing gaming disorder (6C51) as a formal diagnosis in 2022 with three core criteria (impaired control, increasing priority to gaming, continuation despite negative consequences) over about 12 months with significant impairment. Internet addiction, smartphone addiction, and social media addiction are not formally recognized in either system, though ICD-11's residual "other specified disorders due to addictive behaviours" (6C5Y) can capture some. Estimated prevalences are roughly 1 to 4.6% for gaming disorder and about 7% pooled for internet addiction.

The ongoing controversy is itself an important difference: critics warn of pathologizing normal behavior, argue that substance-derived criteria may not map onto behaviors, and note that problematic gaming may sometimes be a symptom of underlying depression or ADHD rather than a primary disorder. DSM-5 also sets a higher diagnostic threshold for behavioral addictions (at least 5 of 10 for IGD, 4 of 9 for gambling) than for SUDs (2 of 11), reflecting greater caution.

Treatment: convergent psychotherapy, divergent pharmacology

CBT is first-line for both, and its efficacy in gaming disorder is well established: the STICA multicenter randomized trial showed a 69.4% remission rate versus 23.9% for waitlist (OR 10.10), and meta-analyses report large pooled effects, with CBT-plus-mindfulness ranking highest in network meta-analysis. The pharmacological picture, however, highlights the substance/behavior divide:

Treatment element	Substance use disorders	Digital/behavioral addictions
Substitution/agonist therapy	Central (methadone, buprenorphine, nicotine replacement)	None; no exogenous substance to replace
Medical detoxification	Often required; withdrawal can be life-threatening	Not needed; withdrawal is affective, not physiological
Pharmacotherapy	Disorder-specific, FDA-approved agents	Off-label bupropion, escitalopram, methylphenidate; these target comorbid depression or ADHD rather than the behavior itself, with weak evidence
Naltrexone	FDA-approved for alcohol and opioid use disorders	No RCT data in internet gaming disorder; medium effect only in gambling disorder
Treatment goal	Usually abstinence	Often controlled or reduced use, since digital tools are unavoidable in modern life
First-line psychotherapy	CBT	CBT (large effect sizes; STICA trial remission 69.4% vs 23.9% waitlist)

There is no substitution therapy, no detoxification, and no medication with a specific behavioral-addiction indication; medications that help (bupropion, stimulants, SSRIs) largely do so by treating comorbid ADHD or depression. Overall evidence quality for digital-addiction interventions is graded weak, with short follow-up and few active controls.

Clinical bottom line

Digital addictions engage the same mesolimbic reward circuitry, prefrontal control systems, and clinical phenomenology as substance use disorders, and both respond to CBT. But the absence of an exogenous toxin, the affective rather than dangerous withdrawal, the high rates of spontaneous remission, and the absence of addiction-specific pharmacotherapy mean they should not be treated as equivalent entities. Careful assessment should screen for underlying depression, ADHD, and anxiety driving the behavior, and treatment targets controlled use rather than abstinence.

References

American Psychiatric Association. DSM-5: Diagnostic and statistical manual of mental disorders (5th ed.).
Petry NM, Rehbein F, Ko CH, O'Brien CP. Internet gaming disorder in the DSM-5. Current Psychiatry Reports. 2015;17(9):72. doi.org/10.1007/s11920-015-0610-0
Billieux J, Stein DJ, Castro-Calvo J, Higushi S, King DL. Rationale for and usefulness of the inclusion of gaming disorder in the ICD-11. World Psychiatry. 2021;20(2):198-199. doi.org/10.1002/wps.20848
Musetti A, Floros G, Chiappedi M, Stavropoulos V. Gaming disorder in the ICD-11: the state of the game. BMC Psychiatry. 2025;25(1):1114. doi.org/10.1186/s12888-025-07576-8
Weinstein A, Lejoyeux M. Neurobiological mechanisms underlying internet gaming disorder. Dialogues in Clinical Neuroscience. 2020;22(2):113-126. doi.org/10.31887/DCNS.2020.22.2/aweinstein
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry. 2016;3(8):760-773. doi.org/10.1016/S2215-0366(16)00104-8
Li Q, Du M, Xiao J, et al. Divergent neural mechanisms of reward processing and cognitive control in non-substance and substance addiction: a meta-analytic perspective. NeuroImage. 2026;327:121735. doi.org/10.1016/j.neuroimage.2026.121735
Zeng X, Han X, Zheng D, Jiang P, Yuan Z. Similarity and difference in large-scale functional network alterations between behavioral addictions and substance use disorder: a comparative meta-analysis. Psychological Medicine. 2024;54(3):473-487. doi.org/10.1017/S0033291723003434
Starzec S, Starosta J, Zajas A, et al. Scoping review of withdrawal's role in contemporary gaming disorder research. Clinical Psychology Review. 2024;114:102478. doi.org/10.1016/j.cpr.2024.102478
Fernandez DP, Kuss DJ, Griffiths MD. Short-term abstinence effects across potential behavioral addictions: a systematic review. Clinical Psychology Review. 2020;76:101828. doi.org/10.1016/j.cpr.2020.101828
Konkolÿ Thege B, Woodin EM, Hodgins DC, Williams RJ. Natural course of behavioral addictions: a 5-year longitudinal study. BMC Psychiatry. 2015;15:4. doi.org/10.1186/s12888-015-0383-3
Lau JTF, Wu AMS, Gross DL, Cheng KM, Lau MMC. Is internet addiction transitory or persistent? Incidence and prospective predictors of remission of internet addiction among Chinese secondary school students. Addictive Behaviors. 2017;74:55-62. doi.org/10.1016/j.addbeh.2017.05.034
Reed GM, First MB, Billieux J, et al. Emerging experience with selected new categories in the ICD-11: complex PTSD, prolonged grief disorder, gaming disorder, and compulsive sexual behaviour disorder. World Psychiatry. 2022;21(2):189-213. doi.org/10.1002/wps.20960
Gentile DA, Bailey K, Bavelier D, et al. Internet gaming disorder in children and adolescents. Pediatrics. 2017;140(Suppl 2):S81-S85. doi.org/10.1542/peds.2016-1758H
King DL, Billieux J, Delfabbro PH. Screening, assessment and management of gaming disorder: recent evidence and future directions. World Psychiatry. 2025;24(2):268-269. doi.org/10.1002/wps.21319